Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Neubauer

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Scientific Reports|September 23, 2025
Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemiaCharlotte Sommer, Hildegard I D Mack, Madeleine C Killer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyAndreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Journal of Psychosomatic Research|March 18, 2026
Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort studyStefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Blood|May 31, 2002
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisChristian Thiede, Christine Steudel, Brigitte Mohr, et al.
Plos One|April 23, 2015
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for DifferentiationCornelia Brendel, Sabine Teichler, Axel Millahn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2010
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2019
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trialLaura Budau, Christian Wilhelm, Roland Moll, et al.
Journal of Psychosomatic Research|May 25, 2026
Corrigendum to 'Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort study' [Journal of Psychosomatic Research 205 (2026) 112640]Stefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Haematologica|September 8, 2018
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencingElisabeth K M Mack, André Marquardt, Danny Langer, et al.
Cancers|March 6, 2021
IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML CellsFranziska Liss, Miriam Frech, Ying Wang, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Scientific Reports|September 23, 2025
Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemiaCharlotte Sommer, Hildegard I D Mack, Madeleine C Killer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyAndreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Journal of Psychosomatic Research|March 18, 2026
Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort studyStefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Blood|May 31, 2002
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisChristian Thiede, Christine Steudel, Brigitte Mohr, et al.
Plos One|April 23, 2015
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for DifferentiationCornelia Brendel, Sabine Teichler, Axel Millahn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2010
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2019
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trialLaura Budau, Christian Wilhelm, Roland Moll, et al.
Journal of Psychosomatic Research|May 25, 2026
Corrigendum to 'Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort study' [Journal of Psychosomatic Research 205 (2026) 112640]Stefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Haematologica|September 8, 2018
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencingElisabeth K M Mack, André Marquardt, Danny Langer, et al.
Cancers|March 6, 2021
IRF8 Is an AML-Specific Susceptibility Factor That Regulates Signaling Pathways and Proliferation of AML CellsFranziska Liss, Miriam Frech, Ying Wang, et al.
Pageof 23